Home » Topics » Regulatory

Regulatory
RSS

U.S. academic team takes a novel approach to treating prostate cancer

Nov. 24, 1999

Patent for paclitaxel formulations issued to NaPro BioTherapeutics

Nov. 23, 1999

Launch imminent for Fujisawa's new treatment of atopic dermatitis

Nov. 22, 1999

BMS seeks approval in U.S. for Glucophage XR tablets

Nov. 22, 1999

Small patient study indicates potential new indication for leflunomide

Nov. 17, 1999

FDA accepts NDA for tacrolimus ointment

Nov. 16, 1999

Ciba Vision introduces ocular formulation of lomefloxacin in U.K.

Nov. 15, 1999

Synvisc under study for osteoarthritis of the hip

Nov. 11, 1999

Important new indication for Remicade approved by FDA

Nov. 11, 1999

Amgen's epoetin alfa approved in children with chronic renal failure

Nov. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...